Neonatal 17-OH- Progesterone FEIA

Neonatal 17-OH- Progesterone FEIA Specification

Condition
New

Color
Multicolor

Function
Hospital Use

Use
Medical Use

Portable
Yes

Application
For Hospital amd Clinic Purpose

Technology
Modern

Neonatal 17-OH- Progesterone FEIA Trade Information

Minimum Order Quantity
1 Piece

Supply Ability
1 Piece Per Week

Delivery Time
1-6 Week

Main Domestic Market
All India

About Neonatal 17-OH- Progesterone FEIA

Labsystems Diagnostics' Neonatal 17-OH-Progesterone FEIA test is a fluorometric enzyme immunoassay enabling the quantification of 17-hydroxyprogestrone steroid present in blood samples dried on filter paper. The test can be used for the screening of newborn for Congenital Adrenal Hyperplasia (CAH).

overview:

It is a competitive Fluorometric enzyme immunoassay for the quantitative determination of human 17-OH-progesterone from dried blood spots. It measures the 21-hydroxylase deficiency which is by far the most frequent form of CAH (more than 90 % of cases).

Technical Specifications:

Neonatal 17-OH-Progesterone FEIA , 5 strip plates (12x8), 480 wells 6199870
Neonatal 17-OH-Progesterone FEIA, 10 strip plate (12x8), 960 wells 6199872
Neonatal 17-OH-Progesterone FEIA, 10 solid plates (96), 960 wells 6199871

Benefits

Excellent reproducibility
High sensitivity with high signal/background ratio
Calibrated against the latest international references

Advanced Neonatal Diagnosis

Employing cutting-edge FEIA technology, this device delivers reliable and quick detection of 17-OH-Progesterone, a critical marker for congenital adrenal hyperplasia in neonates. It is designed to streamline workflow in hospital and clinic settings, supporting early intervention and timely treatment decisions.

Portable and User-Friendly Design

With its lightweight, portable form and multicolor exterior, this device is easily integrated into diverse medical environments. Healthcare professionals can transport and use the instrument efficiently across wards and clinics, enhancing flexibility and convenience.

FAQs of Neonatal 17-OH- Progesterone FEIA:

Q: How does the Neonatal 17-OH-Progesterone FEIA function in a clinical setting?

A: This device utilizes Fluorescence Enzyme Immunoassay (FEIA) technology to accurately measure 17-OH-Progesterone levels in newborn samples, supporting early detection of hormonal disorders such as congenital adrenal hyperplasia.

Q: What are the primary benefits of using this portable instrument?

A: The main advantages include its portability for on-site use, rapid and reliable results, and adaptability to both hospitals and clinics, providing healthcare teams with vital information for neonatal care.

Q: When is this device typically used in the hospital or clinic workflow?

A: It is most commonly used in neonatal departments shortly after birth, during routine screening or when symptoms of hormonal imbalance are noted in a newborn, allowing for immediate and informed clinical decisions.

Q: Where can this diagnostic tool be set up within a healthcare facility?

A: Thanks to its compact and portable design, the device can be deployed in neonatal intensive care units, maternity wards, outpatient departments, or satellite clinics as required.

Q: What is the process for conducting a test with this FEIA device?

A: A small blood sample is collected from the newborn, prepared according to protocol, and then processed using the device. The FEIA system delivers rapid quantitative results, simplifying workflow for healthcare staff.

Q: Who distributes and manufactures the Neonatal 17-OH-Progesterone FEIA in India?

A: The equipment is manufactured, exported, supplied, and distributed by reputable medical companies in India, ensuring accessibility for healthcare providers throughout the country.